The effect of Vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: Systematic review with meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jamka, Małgorzata ^a   Woźniewicz, Małgorzata ^a   Jeszka, Jan ^a   Mardas, Marcin ^a,b   Bogdański, Paweł ^b   Stelmach Mardas, Marta ^b,c  

^a POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL; INSULIN; VITAMIN D;

ADOLESCENT; ADULT; DIET RESTRICTION; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; META ANALYSIS; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; FASTING; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; VITAMIN D; YOUNG ADULT;

EID: 84946843342     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16142     Document Type: Article

References (52)

1. International Diabetes Federation. IDF Diabetes Atlas, 6th edn. (International Diabetes Federation, Brussels, 2013) Available at: http://www.idf.org/diabetesatlas (Accessed: 2nd January 2015).
2. Daousi, C. et al. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad. Med. J. 82, 280-284 (2006).
3. Smyth, S. & Heron, A. Diabetes and obesity: the twin epidemics. Nat. Med. 2, 75-80 (2006).
4. Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 444, 840-846 (2006).
5. McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C. & Reaven G. Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism. 53, 495-499 (2004).
6. Gandhem, M. B., M, L. & Srinivasan, A. R. Evaluation of body mass index (BMI) percentile cut-off levels with reference to insulin resistance: a comparative study on South Indian obese and non-obese adolescents. J. Clin. Diagn. Res. 7, 1579-1582 (2013).
7. Maestro, B., Molero, S., Bajo, S., Dávila, N. & Calle, C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell. Biochem. Funct. 20, 227-232 (2002).
8. Maestro, B., Dávila, N., Carranza, M. C. & Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J. Steroid. Biochem. Mol. Biol. 84, 223-230 (2003).
9. von Hurst, P. R., Stonehouse, W. & Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, control-controlled trial. Br. J. Nutr. 103, 549-555 (2010).
10. Naharci, I. et al. Effect of vitamin D on insulin sensitivity in elderly patients with impaired fasting glucose. Geriatr. Gerontol. Int. 12, 454-460 (2012).
11. Dutta, D. et al. Vitamin-D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance and systemic inflammation: an open label randomized prospective study from Eastern India. Diabetes. Res. Clin. Pract. 103, e18-e23 (2014).
12. Mitri, J., Dawson-Hughes, B., Hu, F. B. & Pittas, A. G. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. 94, 486-494 (2011).
13. Harinarayan, C. V. et al. Improvement in pancreatic β cell function with vitamin D and calcium supplementation in vitamin D deficient non-diabetic subjects. Endocr. Pract. 20, 129-138 (2013).
14. Baz-Hecht, M. & Goldfine, A. B. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr. Opin. Endocrinol. Diabetes Obes. 17, 113-119 (2010).
15. Bland, R. et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J. Steroid. Biochem. Mol. Biol. 89-90, 121-125 (2004).
16. Shore-Lorenti, C. et al. Shining the light on sunshine: a systematic review of the influence of sun exposure on type 2 diabetes mellitus-related outcomes. Clin. Endocrinol. (Oxf). 81, 799-811 (2014).
17. MacLaughlin, J. & Holick, M. F. Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest. 76, 1536-1538 (1985).
18. Brock, K. et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J. Steroid. Biochem. Mol. Biol. 121, 462-466 (2010).
19. Bray, G. A. & Bellanger, T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 29(1), 109-17 (2006).
20. Kelishadi, R., Salek, S., Salek, M., Hashemipour, M. & Movahedian, M. Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J. Pediatr. (Rio. J.). 90, 28-34 (2014).
21. Mason, C. et al. Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am. J. Clin. Nutr. 99, 1015-1025 (2014).
22. Wamberg, L. et al. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-results from a randomized trial. Eur J Intern Med. 24(7), 644-649 (2013).
23. Belenchia, A. M., Tosh, A. K., Hillman, L. S. & Peterson, C. A. Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am. J. Clin. Nutr. 97, 774-781 (2013).
24. Carrillo, A. E. et al. Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults. Clin. Nutr. 32, 375-381 (2013).
25. Salehpour, A. et al. Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A doubleblind, randomized, control-controlled clinical trial. Diabet. Med. 30, 1477-1481 (2013).
26. Zhu, W. et al. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with verylow calcium consumption: a randomized controlled trial. Nutr. J. 12, 8 (2013).
27. Beilfuss, J., Berg, V., Sneve, M., Jorde, R. & Kamycheva, E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 60, 870-874 (2012).
28. Harris, S. S., Pittas, A. G. & Palermo, N. J. A randomized, control-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes. Metab. 14, 789-794 (2012).
29. Major, G. C., Alarie, F., Doré, J., Phouttama, S. & Tremblay, A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am. J. Clin. Nutr. 85, 54-59 (2007).
30. Nagpal, J., Pande, J. N. & Bhartia, A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet. Med. 26(1), 19-27 (2009).
31. Zittermann, A. et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am. J. Clin. Nutr. 89(5), 1321-1327 (2009).
32. Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 1911-1930 (2011).
33. Kmet, L. M., Lee, R. C. & Cook L. S. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. (Alberta Heritage Foundation for Medical Research, Edmonton, 2004).
34. Wood, A. D. et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J. Clin. Endocrinol. Metab. 97(10), 3557-3568 (2012).
35. Stelmach-Mardas, M., Mardas, M., Warchoł, W., Jamka, M. & Walkowiak J. Successful maintenance of body weight reduction after individualized dietary counseling in obese subjects. Sci. Rep. 4, 6620 (2014).
36. Seida, J. C. et al. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 99(10), 3551-3560 (2014).
37. Gagnon, C. et al. Effects of Combined Calcium and Vitamin D Supplementation on Insulin Secretion, Insulin Sensitivity and β -Cell Function in Multi-Ethnic Vitamin D-Deficient Adults at Risk for Type 2 Diabetes: A Pilot Randomized, Placebo-Controlled Trial. Plos One. 9(10), 1-12 (2014).
38. Stelmach-Mardas, M., Mardas, M., Walkowiak, J. & Boeing, H. Long-term weight status in regainers after weight loss by lifestyle intervention: status and challenges. Proc. Nutr. Soc. 73, 509-518 (2014).
39. Clark, S. A., Stumpf, W. E. & Sar, M. Effect of 1,25 dihydroxyvitamin D 3 on insulin secretion. Diabetes. 30, 382-386 (1981).
40. Cheng, S. et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 59, 242-248 (2010).
41. Hagenau, T. et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos. Int. 20, 133-140 (2009).
42. George, P. S. & Pearson, E. R. Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med. 29, 142-150 (2012).
43. Sollid, S. T. et al. No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care. 37, 2123-312 (2014).
44. Mitri, J., Muraru, M. D. & Pittas, A. G. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 65, 1005-1015 (2011).
45. Jamka, M., Stelmach-Mardas, M., Woźniewicz, M. & Jeszka, J. The effect of vitamin D supplementation on the pancreatic betacell functions in overweight and obese subjects. PROSPERO: CRD42014015366 (2014) Available at: http://www.crd.york.ac.uk/PROSPERO/display-record.asp? ID = CRD42014015366 (Accessed: 25th December 2014).
46. Moher, D. et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med. 21, 6(7) e1000097. doi: 10.1371/journal.pmed.1000097 (2009).
47. World Health Organization. BMI classification. global database on body mass index. Available at: http://apps.who.int/bmi/index.jsp?introPage=intro-3.html (Accessed: 2nd January 2015).
48. Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 363, 157-163 (2004).
49. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 37, Suppl 1, S81-590 (2014).
50. Melmed, S., Polonsky, K. S., Larsen, P. R. & Kronenberg, H. M. Williams textbook of endocrinology. (Elsevier Saunders, Philadelphia, 2011).
51. Gayoso-Diz, P. et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. 16, 13-47 (2013).
52. Normand, S. L. Meta-analysis: formulating, evaluating, combining, and reporting. Stat. Med. 18, 321-359 (1999).